| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |